Evidence map›Paper›PMID 39039619›Full record

ArticleClinical pharmacology and therapeutics2024

From Challenge to Opportunity: How Shwachman-Diamond Syndrome Became a Promising Target for Therapy Development.

Eszter S Hars, Lisa J McReynolds

Abstract read
In one paragraph

Article in Clinical pharmacology and therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eszter S HarsShwachman-Diamond Syndrome Alliance Inc, Woburn, Massachusetts, USA.ORCID https://orcid.org/0000-0003-3674-3562
Lisa J McReynoldsClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-1018-1453

Funding

Intramural NIH HHS Z99 CA999999Intramural Research Program of the National Cancer InstituteThe Chan Zuckerberg InitiativeUniversity of Pennsylvania Orphan Disease Center
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39039619
PMCPMC11567794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.